Alaunos Therapeutics TCRT Estimates

NASDAQ TCRT
$1.55 -0.04 (-2.52%)
As of: Sep 9, 2026 · 3:08 PM EDT
Analyst Estimates

Alaunos Therapeutics, Inc. Revenue Estimates

Periods 20
Next Period Q1 24
Consensus 0.00

Analysts expect Alaunos Therapeutics, Inc. to report revenue of 0.00 for Q1 24, against a range of 0.00 to 0.00.

Metric Q1 24Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28
Reported (Actual) --------
High Estimate 0.000.000.000.00154.80 M151.70 M146.06 M160.94 M
Low Estimate 0.000.000.000.00140.17 M139.70 M119.72 M134.32 M
Consensus Estimate 0.000.000.000.00147.49 M145.70 M132.89 M147.63 M
Analyst Estimates

Alaunos Therapeutics, Inc. Earnings Per Share (EPS) Estimates

Periods 20
Next Period Q1 24
Consensus -4.67

Analysts expect Alaunos Therapeutics, Inc. to report earnings per share of -4.67 for Q1 24, against a range of -4.95 to -4.39.

Metric Q1 24Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28
Reported (Actual) --------
High Estimate -4.39-3.97-4.05-4.31-6.38-4.62-4.98-3.33
Low Estimate -4.95-4.65-4.39-4.89-7.16-5.46-5.40-3.83
Consensus Estimate -4.67-4.31-4.22-4.60-6.77-5.04-5.19-3.58